Answers are grounded in this paper and cite their sources.
Background Mediastinoscopic esophagectomy (ME) has emerged as a minimally invasive alternative to thoracoscopic esophagectomy (TE), particularly for patients with high surgical risk. However, the indications for ME are heterogeneous, and direct comparisons with TE in clinical settings remain limited. This study aimed to evaluate the perioperative and oncological outcomes of ME in selected patients using propensity score matching. Methods We retrospectively reviewed 260 patients who underwent esophagectomy for esophageal cancer, of whom 187 patients who underwent either TE or ME were included in the analysis. At our institution, ME was preferentially selected for patients with advanced age, impaired pulmonary function, comorbidities, or prior thoracic disease, whereas bulky tumors or clinically evident mediastinal lymph node metastases were generally excluded. After propensity score matching using 7 clinically relevant preoperative variables, 34 patients were included in each group. Perioperative outcomes, survival, recurrence patterns, and causes of death were analyzed. Results Overall morbidity, including pneumonia and recurrent laryngeal nerve palsy, did not significantly differ between the TE and ME groups. The number of dissected lymph nodes was significantly lower in the ME group ( P < 0.001). With a median follow-up period of > 50 months, no significant differences were observed in overall survival (OS), relapse-free survival (RFS), or disease-specific survival (DSS). Although OS tended to be longer in the TE group, DSS was comparable between the groups. No apparent increase in locoregional recurrence was observed in the ME group, despite the reduced extent of mediastinal lymphadenectomy. Non-esophageal cancer-related mortality was significantly higher in the ME group ( P < 0.05). Conclusions ME may be a feasible surgical option for selected high-risk patients, with acceptable disease-specific and locoregional control. However, the present findings should be interpreted cautiously because of the retrospective design, limited sample size, heterogeneous indications for ME, and potential residual selection bias.
No takes yet. Share an insight, caveat, or question.
Sasaki et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: